BLOOD-BASED BIOMARKERS FOR PREDICTING POST-STROKE PROGNOSIS: A SCOPING REVIEW OF PENTRAXIN-3, NEUROPENTRAXIN-1, AND NEUROPENTRAXIN-2. Magna Neurologica, [S. l.], v. 4, n. 2, p. 175–186, 2026. DOI: 10.20961/magnaneurologica.v4i2.3308. Disponível em: https://journal.uns.ac.id/index.php/magna-neurologica/article/view/3308. Acesso em: 16 jul. 2026.